Renal and prostatic disorders in the elderly

Indian Journal of Medical Research

Volumn 106, Issue OCT., 1997, Pages 286-294

  Mandhani, Anil ^a   Sanjeevan, K V ^a   Chaurasia, Dilip ^a   Bhandari, Mahendra ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Elderly; Kidney; Prostate; Prostate cancer; Prostatic hyperplasia

Indexed keywords

ACUTE KIDNEY TUBULE NECROSIS; AGED; AGING; ANESTHESIA COMPLICATION; DIALYSIS; ENDOSCOPIC SURGERY; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORPHOLOGY; NEPHROTOXICITY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; REVIEW; RISK;

AGED; HUMANS; INDIA; KIDNEY DISEASES; MALE; PROSTATIC DISEASES; TISSUE DONORS;

EID: 0030667628     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Drecier R, Christopher SC, Williams RD. Management of prostate and bladder cancer in the elderly. Urol Clin North Am 1996; 23: 87-97.
2. Daneshgari F, Crawford ED. Benign prostatic disease: A growing challenge in the 1990s. Postgrad Med 1993; 93: 84-90.
3. Palmer BF, Levi M Renal function and disease in the aging kidney. In: RW Schrier, CW Gottschalk, editors. Diseases of the kidney. Vol III. 6TH edn. Boston : Little, Brown & Co 1997; 2293-317.
4. Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of different races. Gerontologia 1971; 17: 87-97.
5. Hollenberg NK, Adams DF, Solomon HS, Rashid A. Abrams HL, Merrill JP. Senescence and the renal vasculature in normal man. Cir Res 1974; 34: 309-16.
6. McLahan MSF, Guthrie JC, Anderson CK, Fulker MJ. Vascular and glomerular changes in the aging kidney. J Pathol 1977; 121: 65-77.
7. Kaplan C, Pasternack B, Shah H, Gallo G. Age related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80: 227-34.
8. Takazakura E, Sawabu N, Handa A, Takada A, Shinoda A, Takeuchi J. Intrarenal vascular changes with age and disease. Kidney Int 1972; 2: 224-30.
9. McDonald R, Solomon D, Shock N. Aging as a factor in the renal hemodynamic changes induced by a standardised pyrogen. J Clin Invest 1951; 30: 457-62.
10. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-63.
11. Bhandari M. The role of hyperfiltration in progressive renal injury. Curr Opin Urol 1997; 7: 121-5.
12. Böhler J, Glöer D, Reetze-Bonorden P, Keller E, Schollmeyer PJ. Renal functional reserve in elderly patients. Clin Nephrol 1993; 39: 145-50.
13. Epstein M, Hollenberg N. Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med 1976; 87: 411-7.
14. Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol 1994; 5: 1106-11.
15. 4Cl on the blood acid-base equilibria of geriatric subjects. J Am Geriatr Soc 1955; 3: 697-703.
16. Agarwal BN, Cabebe FG. Renal acidification in elderly subjects. Nephron 1980; 26: 291-5.
17. Prasad R, Kinsella JL, Sacktor B. Renal adaptation to metabolic acidosis in senescent rats. Am J Physiol 1988; 255: F1183-90.
18. Allen TH, Anderson EC, Langham WH. Total body potassium and gross body composition in relation with age. J Gerontol 1960; 15: 348-57.
19. Sagild U. Total exchangeable potassium in normal subjects with special reference to changes with age. Scand J Clin Lab Invest 1956; 8: 44-50.
20. Walmsley RN, White GH, Cain M, McCarthy PJ, Booth J. Hyperkalemia in the elderly. Clin Chem 1984; 30: 1409-12.
21. DeFronzo RA. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 1980; 17: 118-34.
22. Alevizaki CC, Ikkos DG, Singheakis P. Progressive decrease of true intestinal calcium absorption with age in normal man. J Nucl Med 1973; 14: 760-2.
23. Armbrecht HJ, Gross CJ, Zenser TV. Effect of dietary calcium and phosphorus restriction balance in young and old rats. Arch Biochem Biophys 1981; 210: 179-85.
24. Meyer BR. Renal functions in aging. J Am Geriatr Soc 1989; 37: 791-800.
25. Corman B, Chami Khazraji S, Schaeverbeke J, Michel JB. Effect of feeding on glomerular filtration rate and proteinuria in conscious aging rats. Am J Physiol 1988; 255: F250-6.
26. Feutren G, Mihatsch M. Risk factors for cyclosporine nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654-60.
27. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993; 118: 712-9.
28. Meyrier A, Buchet P, Simon P, Fernet M, Rainfray M, Callard P. Atheromatous renal disease. Am J Med 1988; 85: 139-46.
29. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment - a case for treatment. Clin Nephrol 1989; 31: 119-22.
30. Kissane JM. The morphology of renal cystic disease. Perspect Nephrol Hypertens 1976; 39: 31-63.
31. Ravine D, Gibson RN, Doular J, Sheffield LJ. An ultrasound renal cyst prevalence survey: Specificity data for inherited renal cystic diseases. Am J Kid Dis 1993; 22: 803-7.
32. Pollack HM, Banner MP, Arger PH, Peters J, Mulhern CB, Coleman BG. The accuracy of grey-scale renal ultrasonography in differentiating cystic neoplasm from benign cysts. Radiology 1982; 143: 741-5.
33. Churchill DN, Bear JC, Morgan J, Payne RH, McManamon PJ, Gault MH. Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int 1984; 26: 190-3.
34. Lynch TH, Waymont B, Dunn J, Hughes MA, Wallace DMA. Repeat testing for hematuria and underlying urological pathology. Br J Urol 1994; 74: 730-73.
35. Ismail N, Hakim RM, Dimitrios G, Patricarea A, Oreopoulos DG. Renal replacement therapies in the elderly: Part I. Haemodialysis and peritoneal dialysis. Am J Kidney Dis 1993; 22: 759-82.
36. Ismail N, Hakim RM, Helderman JH. Renal replacement therapies in the elderly: Part II. Renal transplantation. Am J Kid Dis 1994; 23: 1-15.
37. Korb SM, Pustay M, Kolovich R, Blackburns Light JA. Renal transplantation of organs from donors over 50 years of age. Transplant Proc 1989; 21: 1940-1.
38. Sakellariou G, Daniilidis M, Alexopoulos E, Karagiannis A, Papadimitriou M. Does the donor age influence graft survival in renal transplantation. Transplant Proc 1987; 19: 2071-3.
39. Alexander JW, Bennett LE, Breen JT. Effect of donor age on outcome of kidney transplantation. Transplantation 1994; 57: 871-6.
40. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9.
41. Carlström K, Stage R. Testicular and adrenocortical function in men with prostate cancer and in healthy age matched controls. Br J Urol 1997; 79: 427-31.
42. Shapiro E, Hartanto V, Lepor H. Quantifying the smooth muscle content of the prostate using double immunoenzymatic staining and color assisted image analysis. J Urol 1992; 147: 1167-70.
43. McNeal JE. The prostate gland: Morphology and pathobiology. Monogr Urol 1983; 4: 3-33.
44. Hudson RW, Moffitt PM, Owens WA. Studies of the nuclear 5α-reductase of human prostatic tissue: Comparison of enzyme activities in hyperplastic, malignant and normal tissues. Can J Biochem Cell Biol 1983; 61: 750-5.
45. Coffey DS. The molecular biology of the prostate. In: Lepor H, Lawson RK, editors. Prostate diseases. Philadelphia : WB Saunders Co. 1993; 28.
46. Steiner G, Gessl A, Kramer G, Schollhammer A, Forste O, Marberger M. Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia. J Urol 1994; 151: 480-4.
47. Theyer G, Kramer G, Assman T, Sherwood E, Preinfalk W, Marberger M. Phenotypic characterization of infiltrating leukocytes in BPH. Lab Invest 1992; 66: 96-107.
48. Langenstroer P, Tang R, Shapiro E, Divish B, Opgenorth T, Lepor H. Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J Urol 1993; 149: 495-9.
49. Elbadavi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction-1. Methods of a prospective ultrastructural/urodynamic study and an overview of the findings. J Urol 1993; 150: 1650-6.
50. Schoenberg HW, Gutrich JM, Cote R. Urodynamic studies in benign prostate hypertrophy. Urology 1979; 14: 634-7.
51. Guess HM. Natural history of benign prostatic hyperplasia. In: NA Romas, ED Vaughn, editors. Alternate methods in the treatment of benign prostatic hyperplasia. Berlin : Springer-Verlag 1993; 1.
52. Sarmina I, Resnick MI. Obstructive uropathy in patients with benign prostatic hyperplasia. J Urol 1989; 141: 866-9.
53. Drecier R, Christopher SC, Williams RD. Management of prostate and bladder cancer in the elderly. Urol Clin North Am 1996; 23: 87-97.
54. Partin AW, Criley SR, Subong ENP, Zinkey H, Walsh PC, Oesterling JE. Standard versus age specific PSA reference ranges among men with clinically localised prostate cancer: A pathological analysis. J Urol 1996; 155: 1336-9.
55. Wolff JM, Borcher H, Effert PJ, Habib FK, Jakse G. Free to total PSA serum concentration in patient with prostate cancer and BPH. Br J Urol 1996; 78: 409-13.
56. Zlotta AR, Djavan B, Marberger M, Schulman CC. Prostate specific antigen density of the transition zone: A new effective parameter for prostate cancer prediction. J Urol 1997; 157: 1315-21.
57. Osterling JE, Os Jacobsen SJ, Klee GG, Kim P, Piironen T, Abrahamsson PA, Stenman UH, Dowell B, Lövgren T, Lilja H. Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 1995; 154: 1090-5.
58. Smith JA Jr. Stage A cancer of the prostate in clinical management of prostate cancer. Chicago : Yearbook Medical Publisher 1988; 85-96.
59. Zincke H, Blute ML, Fallen MJ, Farrow MJ. Radical prostatectomy for stage A adenocarcinoma of the prostate: Staging errors and their implication for treatment recommendations and disease outcome. J Urol 1991; 146: 1053-8.
60. 2 and B diseases. J Urol 1991; 146: 1059-63.
61. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localised prostate cancer. J Am Med Assoc 1993; 269: 2650-8.
62. Beck JR, Kattan MW, Miles BJ. A critique of the decision analysis for clinically localized prostate cancer. J Urol 1994; 152: 1894-9.
63. Whitmore WF. Natural history of low stage prostate cancer and the impact of early detection. Urol Clin North Am 1990; 17: 689-97.
64. Stamey TA. Cancer of the prostate: Analysis of some important contributions and dilemmas. Monogr Urol 1982; 3: 67-94.
65. The Medical Research Council prostate cancer working party investigators group. Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial. Br J Urol 1997; 79: 235-46.
66. Daniel HW. Osteoporosis after orchiectomy for prostate cancer. J Urol 1997; 157: 439-44.
67. Stepan JJ, Lachman M, Verina JZ, Pacovasky V, Baylink DJ. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodelling. J Clin Endocrinol Metab 1989; 69: 523-7.
68. Beckendorf V, Hay M, Rozan R, Lagrange JL, N'Guyen T, Giraud B. Changes in sexual function after radiotherapy treatment of prostate cancer. Br J Urol 1996; 77: 118-23.
69. Bagshaw MA. Potential for radiotherapy in prostate carcinoma. Cancer 1985; 55: 2079-85.
70. Gohagan JK, Prork PC, Kramer BS, Hayes RB, Cornett JE. The prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. Cancer 1995; 75: 1869-73.
71. Wilt TZ, Brawer MK. The prostate cancer intervention versus observation trial (PIVOT). Cancer 1995; 75: 1963-8.
72. Lu-Yao GL, Mc Lerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy: Time trends, geographic variation and outcome. J Am Med Assoc 1993; 269: 2633-6.
73. Mark DH. Mortality of patients after radical prostatectomy: Analysis of recent Medicare claims. J Urol 1994; 152: 896-8.
74. Steiner MS, Morton RA, Walsh PC. Impact of anatomical radical prostatectomy on urinary continence. J Urol 1991; 145: 512-5.
75. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993; 150: 905-7.
76. Gronberg H, Damber JE, Jonsson H, Lenner P. Patients' age as a prognostic factor in prostatic cancer. J Urol 1994; 152: 892-5.
77. Buxbaum JL, Schwartz AJ. Perianaesthetic consideration for the elderly patient. Surg Clin North Am 1994; 74: 41-58.
78. Marx GF, Mateo CV, Orkin LR. Computer analysis of post anaesthetic deaths. Anaesthesiology 1973; 39: 54-8.
79. Gordon M, Cheung M. Poor outcome of on site CPR in a multilevel geriatric facility: Three and half years experience at the Bay Crest Center for Geriatric Care. J Am Geriatr Soc 1993; 41: 163-6.
80. Merrell WJ. Anesthetic considerations. In: PD O'Donnell, editor. Geriatric urology. Boston : Little Brown & Co. 1994; 61.